Moreover, chemotherapy promotes ROS generation that could facilitate tumor cell survival through activating NF-κB, thereafter upregulating the anti-apoptotic gene Bcl-XL and enhancing GBM survival and chemotherapy resistance [94]. The gene discussed is BCL2L1; the disease is neoplasm.